Program Agenda
This web page is archived for historical purposes and is no longer being updated.
Agenda At-a-Glance Conference Program Book
CONFERENCE AT-A-GLANCE
TUESDAY, SEPTEMBER 20
8:00 am - 4:00 pm |
Pre-Conference Meetings |
11:00 am - 5:00 pm |
Registration/ Information Open |
5:00 pm – 6:20 pm |
Opening Plenary / The Ward Cates Memorial Lecture |
6:30 pm – 8:30 pm |
Welcome Reception |
WEDNESDAY, SEPTEMBER 21
7:00 am - 4:00 pm |
Registration/ Information Open |
7:00 am – 8:15 am |
Continental Breakfast |
7:00 am – 7:50 am |
Clinical Case Series 1 |
8:00 am – 9:00 am |
Plenary Session 1/ Jack Spencer Award |
9:30 am – 10:30 am |
Mini-Plenary Sessions 1 and 2 |
10:45 am – 12:00 pm |
Concurrent Sessions 1A-E |
12:00 pm – 1:30 pm |
Lunch Break/ Conference Partners Symposium |
1:30 pm – 2:30 pm |
Plenary Session 2 |
3:00 pm – 4:15 pm |
Concurrent Sessions 2A-E |
4:30 pm – 6:00 pm |
Debates 1 & 2 |
6:00 pm – 6: 45 pm |
Scientific Poster Session 1/Poster Grand Rounds |
6:45 pm – 7: 30 pm |
ASHA Movie Presentation |
THURSDAY, SEPTEMBER 22
7:00 am - 4:00 pm |
Registration/ Information Open |
7:00 am – 8:15 am |
Continental Breakfast |
7:00 am – 8:00 am |
ASTDA Breakfast Symposium |
7:00 am – 7:50 am |
Clinical Case Series 2 |
8:00 am – 9:00 am |
Plenary Session 3 |
9:30 am – 10:30 pm |
Mini-Plenary Sessions 3 and 4 |
10:45 pm – 12:00 pm |
Concurrent Sessions 3A-F |
12:00 pm – 1:30 pm |
Lunch Break/ ASTDA Awards Luncheon |
1:30 pm – 2:30 pm |
Plenary Session 4 |
3:00 pm – 4:15 pm |
Concurrent Sessions 4A-E |
4:40 pm – 5: 40 pm |
Debates 3 and 4 |
5:45 pm – 6: 30 pm |
Scientific Poster Session 2/Poster Grand Rounds |
6:45 pm – 9:00 pm |
Networking Event |
FRIDAY, SEPTEMBER 23
7:00 am - 11:30 pm |
Information Open |
7:00 am - 8:15 am |
Continental Breakfast |
7:00 am – 7:50 am |
Clinical Case Series 3 |
8:00 am – 9:15 am |
Concurrent Sessions 5A-E |
9:30 am -10:45 am |
Concurrent Sessions 6A-E |
11:15 am - 12:15 pm |
Rapporteur Session |
12:15 pm - 1:10 pm |
Closing Plenary |
1:10 pm - 1:30pm |
ASTDA Talk & Poster Awards/ Closing Remarks |
Monday, September 19, 2016
8:30 am - 4:00 pm |
U.S. Affiliated Pacific Islands Grantees Meeting |
Tuesday, September 20, 2016
8:30 am - 2:00 pm |
Community Approaches To Reducing STDs Grantees Meeting |
8:30 am - 5:00 pm |
U.S. Affiliated Pacific Islands Grantees Meeting |
8:30 am - 3:00 pm |
Field Services Branch Meeting (Breakout Rooms) |
9:00 am - 5:00 pm |
STD 101 STD 101 is based on a workshop at the 2014 National STD Prevention Conference in Atlanta, Georgia. That workshop provided participants who had limited or no STD prevention experience a basic knowledge of STD prevention so that they could actively participate in the conference. STD 101 in a Box now provides users with materials for developing similar workshops. The downloadable materials are customizable for conferences, group discussions, and presentations. Topics include STD clinical and behavioral information, HIV and STD interrelationships, STD epidemiology, and STD prevention program information. Potential users include but are not limited to community-based organizations, public health departments, and schools of public health, health educators, primary care providers, and disease intervention specialists. |
11:00 am - 5:00 pm |
REGISTRATION/INFORMATION OPEN |
1:00 pm - 3:30 pm |
STD Surveillance Coordinators Meeting |
9:00 am–4:00 pm |
Field Epi Unit |
1:00 pm - 4:00 pm |
Grantee Meeting for DSTDP Enhanced Evaluation Awardees |
1:00 pm - 4:30 pm |
Technology-Based HIV and STD Prevention: From Partner Services to Messaging to Structural Interventions This informational and interactive session will provide updates on the best practices for using technology to reach populations at risk with health information and for improving partner services. Current collaborations with business owners in developing structural interventions for STD and HIV prevention also will be discussed. Frank Strona and Rachel Kachur of the working group Using Technology to Advance STD/HIV Prevention Services will introduce CDC’s newly released toolkit for technology-based partner services, provide an introductory overview of the common features found on popular sex-seeking mobile apps, and update participants on other available resources and technical assistance opportunities. Dan Wohlfeiler, Director, Building Healthy Online Communities, will describe their efforts in leveraging partnerships with business owners to develop structural interventions for increasing awareness about STD/HIV prevention. The partnerships synthesize health department activities and messaging to maximize impact and cross-jurisdiction collaboration, and these interventions help users of dating and hook-up sites make informed choices. Time permitting, participants will be able to network with colleagues, learn how different programs use technology for partner services, and explore cross-jurisdictional opportunities. |
3:00 pm - 4:00 pm |
Syphilis Prevention in the United States: Where do we go from here? An overview of the 2016 Syphilis Summit and discussion about next steps in national syphilis prevention. |
3:30 pm -5:30 pm |
Sexually Transmitted Diseases Editorial Board Meeting |
On This Page
Tuesday, September 20, 2016
Wednesday, September 21, 2016
Thursday, September 22, 2016
Friday, September 23, 2016
11:00 am – 5:00 pm Registration/ Information Open
5:00 pm – 6:20 pm OPENING PLENARY / The Ward Cates Memorial Lecture
PrEPortunity for STD Control
Sheena McCormack, MBBS, MSc, FRCP, Dip Ven bio
University College London, Chelsea & Westminster Hospital
London, England, United Kingdom
6:30 pm – 8:30 pm Welcome Reception
7:00 am – 4:00 pm Registration/ Information Open
7:00 am – 8:15 am Continental Breakfast
7:00 am – 7:50 am Clinical Case Series 1
Ocular Syphilis: A Need to Look for Cases in All Exposed Populations
Sancta St. Cyr, M.D., Ribka Berhanu, M.D. and Arlene C. Sena, MD, MPH, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC
Painless Jaundice and Transaminitis As a Presentation of Secondary Syphilis
Teresa Batteiger, MD, Department of Internal Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN
8:00 am – 9:00 am PLENARY SESSION 1
Microbiome and Local Immune Response
The Impact of Genital Infections and the Genital Microbiome on Mucosal and Systemic Immunology
Rupert Kaul, MD, PhD, FRCP(C)
University of Toronto
Toronto, Ontario, Canada
Molecular Tools for Studying Human Microbial Communities: Implications for STD research and Diagnostics
David Fredericks, MD, MS
University of Washington,
Seattle, Washington
9:30 am – 10:30 am MINI-PLENARY SESSIONS 1
Transforming Old Problems into New Solutions
Syphilis Control in the Post-elimination Era
Matthew Golden, MD, MPH
University of Washington, Public Health -
Seattle & King County, HIV/STD Program
Seattle, Washington
Gonococcal Resistance—Perspectives from 30 years of GISP
Jonathan Zenilman, MD
Johns Hopkins University School of Medicine
Baltimore, Maryland
Technology Innovations in STD Prevention and Control
Patrick Sullivan, PhD, DVM
Emory University Rollins School of Public Health
Atlanta, Georgia
MINI-PLENARY SESSION 2
Critical Contributors to STD Prevention
Using a Sexual Health Approach to Improve Patient Care and Public Health
Edward Hook, III, MD
University of Alabama School of Medicine
Birmingham, Alabama
Update on STI Vaccine Progress
Helen Rees, MD, MA, MRCGP
World Health Organization, Wits Reproductive Health and HIV Institute
Johannesburg, South Africa
The Transformation of American Healthcare: The Appreciation of Value
Otis Brawley, MD, FACP
Emory University School of Medicine, Winship Cancer Center
Atlanta, Georgia
10:45 am–12:00 pm Concurrent Sessions 1A–E
1A | Oral Presentation | Anogenital Warts and All: STD Vaccines, EPT, and Disseminated Gonococcal Infections |
1B | Oral Presentation | Keeping Out the Bugs: Novel Strategies To Improve STI Screening |
1C | Oral Presentation | Does It Fit the Bill? The Impact of the ACA on STD Programs |
1D | Symposium | Syphilis: Reemerging Clinical Disease and Point-of-Care Tests |
1E | Symposium | New Directions in Addressing Adolescent STD Risk |
12:00 pm – 1:30 pm Lunch Break/ Conference Partners Symposium
1:30 pm – 2:30 pm PLENARY SESSION 2
How to Prevent STDs Without Doing STD Prevention: Policies To Address Poverty and Other Social Determinants of Health
A Social Justice Approach to STD Prevention
Mary Bassett, MD, MPH
New York City Department of Mental Health and Hygiene
New York City, New York
Poverty, Public Policy and Public Health
Sheldon Danziger, PhD
Russell Sage Foundation
New York, New York
3:00 pm – 4:15 pm Concurrent Sessions 2A–E
2A | Oral Presentation | Analyze This! Using Data To Inform STD Prevention |
2B | Oral Presentation | From PrEParation to Implementation |
2C | Oral Presentation | School as a Tool for Combating STDs in Youth |
2D | Symposium | STD/HIV Criminalization- and Incarceration-Related Policies: What Is the Impact on STD Prevention? |
2E | Symposium | The Role of Sexual Transmission in Non-STI Pathogens |
4:30 – 6:00 pm DEBATE SESSIONS
Debate 1
Should We Be doing EPT for MSM?
Jonathan Mermin, MD, MPH
Centers for Disease Control & Prevention
Atlanta, Georgia
Matthew Golden, MD, MPH
University of Washington, Public Health - Seattle & King County,
HIV/STD Program
Seattle, Washington
Debate 2
Is it Okay if MSM get STIs, Just Not HIV?
Myron S. Cohen, MD
University of North Carolina School of Medicine
Chapel Hill, North Carolina
Laura Bachmann, MD, MPH
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina
6:00 - 6:45 Scientific Poster Session 1/Poster Grand Rounds
7:00 am – 4:00 pm Registration/ Information Open
7:00 am – 8:15 am Continental Breakfast
7:00 am – 8:00 am ASTDA Breakfast Symposium
7:00 am – 7:50 am Clinical Case Series 2
A Perfect Storm of Noncompliance: Chlamydia Trachomatis Infection and Progressive Pelvic Inflammatory Disease in an Adolescent Patient
Zoon Wangu, MD, Suzanne C. Allen, MSN, CPNP and Christina R. Hermos, MD, MS, Division of Pediatric Infectious Diseases & Immunology, UMass Memorial Children's Medical Center, Worcester, MA, Division of Adolescent Medicine, UMass Memorial Children's Medical Center, Worcester, MA
Correct Diagnosis of Lymphogranuloma Venereum Makes All the Difference
Deborah Richmond, NP-C, Lawrence R Crane, MD FACP FIDSA, James B. Kent, MS, Paul Lephart, PhD, D(ABMM), Elizabeth A Secord, MD, Hossein Salimnia, Ph.D., D(ABMM) and Jonathan Allen Cohn, MD MS FACP FIDSA, Wayne State University Tolan Park Medical Building, Wayne State University, Detroit, MI, Epidemiology / HIV-Body Art-Viral Hepatitis-STD, Michigan Department of Health and Human Services, Lansing, MI, Detroit Medical Center University Laboratories, Detroit Medical Center, Detroit, MI, Children's Hospital of Michigan, Wayne State University, Detroit, MI, Detroit Medical Center University Laboratories, Wayne State University, Detroit, MI
8:00 am – 9:00 am PLENARY SESSION 3
Social Justice for Sexual and Racial Minorities
Justice or Just Us?
Mandy Carter
National Black Justice Coalition
Durham, North Carolina
Sexual Rights, Social Justice and Minoritized Groups
Eleanor Maticka-Tyndale, PhD
University of Windsor
Windsor, Ontario, Canada
9:30 – 10:30 am MINI-PLENARY SESSION 3
STD Prevention in the Context of Biomedical Interventions to Prevent HIV and Unintended Pregnancy
HIV Pre-Exposure Prophylaxis (PrEP) and Sexually Transmitted Infections (STI)
Demetre Daskalakis, MD, MPH
New York City Department of Health and Mental Hygiene
New York City, New York
The Nexus of LARC Use and STD Testing
Clare Coleman, BA
National Family Planning and Reproductive Health Association
Washington, DC
Preventing HIV, STI, and Unintended Pregnancy in Women At Risk: Evolving Evidence and Approach
Jeanne Marrazzo, MD, MPH
University of Alabama School of Medicine
Birmingham, Alabama
MINI-PLENARY SESSION 4
Understanding Gender Identity: Neurodevelopmental Underpinnings, Gender Fluidity, and Creating Better Outcomes for Sexual Minorities
Gender Fluidity and Gender Identity Development
Aron C. Janssen, MD
New York University School of Medicine
New York City, New York
Transgender Populations: Epidemiology and Best Practices in STD Prevention and Care
Tonia Poteat, PhD, PA-C, MPH
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
Impact of Social Policy on the Well-Being of LGB Populations
Ellen D. B. Riggle, PhD
University of Kentucky
Lexington, Kentucky
10:45 am–12:00 pm Concurrent Sessions 3A–F
3A | Oral Presentation | Point-of-Care Tests Are Here, But Are They Useful? |
3B | Oral Presentation | Making Networks Work for STD Prevention in MSM |
3C | Oral Presentation | Do “Techno” for an Answer: Using Technology To Increase Data Yield |
3D | Symposium | Beyond Chlamydia and Gonorrhea: The Epidemiology of Less Common Sexually Transmitted Pathogens |
3E | Symposium | What Does It Mean To Be “LGBT-Friendly”? Creating Safe Inclusive Environments in Schools and Clinics |
3F | Oral Presentation | Late-Breaker Presentations |
12:00 pm – 1:30 pm Lunch Break/ ASTDA Awards Luncheon
1:30 pm – 2:30 pm PLENARY SESSION 4
Temporal Changes in Demographic and Health Systems
The Role of Burden of Disease, Cost-Effectiveness and Technical Efficiency in Improved Strategic Decision-Making
Nicholas Kassebaum, MD
University of Washington
Seattle, Washington
America’s Changing Population and Family Structures: Emerging Challenges for STD Prevention
Steven Martin, PhD
Urban Institute
Washington, DC
3:00–4:15 pm Concurrent Sessions 4A–E
4A | Oral Presentation | Clinical Controversies in Women’s STD Care |
4B | Oral Presentation | Helping Your Data Get More Action: What To Do About Syphilis and MSM |
4C | Oral Presentation | The Love Shack and Other Tales of the City |
4D | Symposium | Public Health Informatics |
4E | Symposium | Innovative Models of Supporting Quality STD Care |
4:40 – 5:40 pm DEBATE SESSIONS
Debate 3
Are Use of Non-Microscopic Bacterial Vaginosis (BV) POC Tests Sufficient for Clinical Management of BV?
Caroline Mitchell, MD
Harvard Medical School, Massachusetts General Hospital
Boston, Massachusetts
Jeanne Marrazzo, MD, MPH
University of Alabama School of Medicine
Birmingham, Alabama
Debate 4
Can Alcohol Taxes Impact STD Rates?
David Jernigan, PhD
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
William C. Miller, MD, PhD, MPH
The Ohio State University College of Public Health
Columbus, Ohio
5:45 pm – 6: 30 pm Scientific Poster Session 2/Poster Grand Rounds
6:45 pm – 9:00 pm Networking Event
7:00 am – 11:30 pm Information Open
7:00 am – 8:15 am Continental Breakfast
7:00 am – 7:50 am Clinical Case Series 3
An Unexpected Bleed: A Case of Syphilitic Aortitis
Xuan Gao, M.D., Tina Wang, M.D., Steven Leung, M.D., Bella Mehta, M.D., Doruk Erkan, M.D., M.P.H and Barry Hartman, M.D., Department of Medicine, Mount Sinai Beth Israel, New York, NY, Department of Rheumatology, Hospital for Special Surgery, New York, NY, Department of Infectious Disease, New York-Presbyterian/Weill Cornell Medical Center, New York, NY
Cardiovascular Syphilis Requiring Aortic Valve and Arch Surgical Repair in an HIV-Infected Patient
Daniel Graciaa, MD, MPH, Marina Mosunjac, MD, Alan Pillay, PhD, Yetunde Fakile, PhD, Sherif Zaki, MD, PhD, Kimberly Workowski, MD and Russell Kempker, MD, MSc, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Pathology, Emory University School of Medicine, Atlanta, GA, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, Infectious Disease Pathology Branch, NCEZID, Centers for Disease Control and Prevention, Atlanta, GA, Department of Medicine, Div. of Infectious Disease, Emory University School of Medicine, Atlanta, GA, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA
8:00–9:15 am Concurrent Sessions 5A–E
5A | Oral Presentation | Teenage Wasteland: Helping Providers Get It Right |
5B | Oral Presentation | Clinic-Based Interventions: Novel, Fast, and Lean |
5C | Oral Presentation | Congenital Syphilis and Other Perinatal Complications |
5D | Symposium | The Vaginal Microenvironment: Impact on Risk of STI Acquisition |
5E | Symposium | The Intersection of Policy, Science, and Population Health: Pulling on the Levers of Industry, Economics and Political Will for STD Prevention |
6A | Oral Presentation | Cutting Edge Clinical Care for MSM |
6B | Oral Presentation | Leveraging Campaigns and Technology To Achieve Sexual Health |
6C | Oral Presentation | Women’s Sexual and Reproductive Health Opportunities for Intervention |
6D | Symposium | Combatting Antibiotic Resistant Bacteria/Advanced Molecular Detection and Resistant Neisseria gonorrhoeae |
6E | Symposium | Assessment of STDs: Moving Beyond Counting Cases |
11:15 am – 12:15 pm Rapporteur Session
12:15 pm – 1:10 pm CLOSING PLENARY SESSION
Collaborative Diagnosis: Addressing the Social Determinants of Health to Improve Outcomes
Sylvia Caley, JD, MBA, RN bio
Georgia State University, College of Law
Atlanta, Georgia
1:10 pm – 1:30 pm ASTDA Talk & Poster Awards/ Closing Remarks
- Page last reviewed: August 2, 2016 (archived document)
- Content source: